[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934

[ ] TRANSACTION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934

ADM TRONICS UNLIMITED, INC.
(Exact name of registrant as specified in its charter)

224-S Pegasus Ave., Northvale, New Jersey 07647
(Address of Principal Executive Offices)

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: YES [X] NO [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES [X] NO [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

State the number of shares outstanding of each of the Issuer's classes of common equity, as of the latest practicable date:

67,008,502 shares of Common Stock, $.0005 par value, as of ~~August 14,~~November 20, 2015.

	June 30,			March 31,			September 30,			March 31,
	2015			2015			2015			2015
	(Unaudited)						(unaudited)
ASSETS

Current assets:
Cash and cash equivalents	$	370,526		$	216,395		$	942,143		$	216,395
Accounts receivable, net of allowance for doubtfulaccounts of $25,000 for each period		750,803			616,070			800,813			616,070
Inventories		166,792			137,704			193,749			137,704
Prepaid expenses and other current assets		29,414			16,595			21,595			16,595
Restricted cash		232,786			232,525			232,874			232,525
Deferred tax asset								410,000			-

Total current assets		1,550,321			1,219,289			2,601,174			1,219,289

Property and equipment, net of accumulated depreciationof $74,522 and $74,070, respectively		2,794			3,246
Property and equipment, net of accumulated depreciationof $74,972 and $74,070, respectively								2,344			3,246

Inventories - long-term portion		84,904			88,257			74,639			88,257
Intangible assets, net of accumulated amortizationof $154,015 and $153,667, respectively		14,133			14,481
Intangible assets, net of accumulated amortizationof $154,365 and $153,667, respectively								13,784			14,481
Other assets		16,144			16,144			16,144			16,144
Deferred tax asset								447,000			-
Total other assets		117,975			122,128			553,911			122,128

Total assets	$	1,668,296		$	1,341,417		$	3,155,085		$	1,341,417

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
Note payable - bank	$	114,966		$	121,966		$	108,966		$	121,966
Accounts payable		173,216			329,291			238,754			329,291
Accrued expenses and other current liabilities		266,840			221,106			271,128			221,106
Customer deposits		99,102			99,102			99,102			99,102
Due to shareholder		233,841			223,849			249,606			223,849
Total current liabilities		887,965			995,314			967,556			995,314

Total liabilities		887,965			995,314			967,556			995,314

Stockholders' equity:
Preferred stock, $.01 par value; 5,000,000 shares authorized,no shares issued and outstanding		-			-			-			-
Common stock, $0.0005 par value; 150,000,000 authorized, 64,939,537 shares issued and outstanding at March 31, 2015 and 2014, respectively		32,470			32,470
Common stock, $0.0005 par value; 150,000,000 authorized, 67,008,502 and 64,939,537 shares issued and outstanding at September 30, 2015 and March 31, 2015, respectively								33,504			32,470
Additional paid-in capital		32,298,094			32,298,094			33,195,759			32,298,094
Accumulated deficit		(31,550,233	)		(31,984,461	)		(31,041,734	)		(31,984,461	)
Total stockholders' equity		780,331			346,103			2,187,529			346,103

Total liabilities and stockholders' equity	$	1,668,296		$	1,341,417		$	3,155,085		$	1,341,417

2015

2014

Net revenues
$ 1,055,928 $ 623,674

Cost of sales
300,873 338,216

Gross Profit
755,055 285,458

Operating expenses:

Research and development
24,689 12,045
Selling, general, and administrative
295,221 236,037
Depreciation and amortization
597 1,642

Total operating expenses
320,507 249,724

Income from operations
434,548 35,734

Other income (expense):

Interest income
321 1,047
Interest expense
(641 ) (953 )
Total other income (expense)
(320 ) 94

Net income
$ 434,228 $ 35,828

Basic and diluted net income per common share:
$ 0.01 $ 0.00

Weighted average shares of common stock outstanding - basic
64,939,537 64,939,537

Weighted average shares of common stock outstanding - diluted
65,539,537 65,539,537

	2015			2014			2015			2014
Cash flows from operating activities:
Net income	$	434,228		$	35,828
Adjustments to reconcile net income to netcash provided (used) in operating activities:
Net income (loss)							$	942,727		$	165,198
Adjustments to reconcile net loss to netcash used in operating activities:
Stock based compensation								598,699			-
Depreciation and amortization		800			1,642			1,600			3,054
Interest receivable		-			(1,047	)		-			(2,106	)
Deferred income tax								(857,000	)		-
Increase (decrease) in cash flows as a result of changes innet assets and liabilities balances:
Accounts receivable		(134,733	)		(111,136	)		(184,743	)		(164,620	)
Inventory		(25,736	)		(82,996	)
Inventories								(42,427	)		(183,704	)
Prepaid expenses and other current assets		(12,818	)		(23,838	)		(5,000	)		(5,819	)
Other assets		-			(1,000	)
Accounts payable		(156,075	)		47,442			(90,538	)		51,282
Customer deposit								-			103,492
Accrued expenses and other current liabilities		45,734			125,843			50,022			60,369
Due to shareholder		9,992			-			25,757			57,894
Total adjustments		(272,836	)		(45,090	)		(503,630	)		(80,158	)
Net cash provided (used) in operating activities		161,392			(9,262	)
Net cash provided by operating activities								439,097			85,040

Cash flows from investing activities:
Investment in Angiodroid								-			(1,000	)
Restricted cash		(261	)		-			(349	)		(261	)
Net cash used in investing activities		(261	)		-
Net cash used by investing activities								(349	)		(1,261	)

Cash flows used in financing activities:
Cash flows provided (used) in financing activities:
Repayments on note payable - Bank		(7,000	)		(4,000	)		(13,000	)		(7,000	)
Sale of common stock								300,000			-

Net cash used in financing activities		(7,000	)		(4,000	)

Net increase (decrease) in cash and cash equivalents		154,131			(13,262	)
Net cash provided by (used) in financing activities								287,000			(7,000	)

Net increase (decrease) in cash								725,748			76,779

Cash and cash equivalents - beginning of year		216,395			83,156			216,395			83,156

Cash and cash equivalents - end of year	$	370,526		$	69,894		$	942,143		$	159,935

Supplementary Disclosures of Cash Flow Information

Cash paid for:
Interest	$	641		$	953		$	1,471		$	1,693

NOTE 1 - NATURE OF BUSINESS

ADM Tronics Unlimited, Inc. ("we", "us", the “Company" or "ADM"), was incorporated under the laws of the state of Delaware on November 24, 1969. We are an engineering and manufacturing concern whose principal lines of business are engineering and manufacturing of electronics, primarily medical electronic devices, and the development, production and sale of chemical products.

The accompanying condensed consolidated financial statements as of ~~June~~September 30, 2015 (unaudited) and March 31, 2015 and for the three and six month periods ended ~~June~~September 30, 2015 and 2014 (unaudited) have been prepared by ADM pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) including Form 10-Q and Regulation S-X. The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments) which are, in the opinion of management, necessary to fairly present the condensed financial position and operating results for the respective periods. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted pursuant to such rules and regulations. These condensed consolidated financial statements and the information included under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operations" should be read in conjunction with the audited financial statements and explanatory notes for the year ended March 31, 2015 as disclosed in our annual report on Form 10-K for that year . The operating results and cash flows for three and six months ended ~~June~~September 30, 2015 (unaudited) are not necessarily indicative of the results to be expected for the pending full year ending March 31, 2016.

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES

PRINCIPLES OF CONSOLIDATION

The condensed consolidated financial statements include the accounts of ADM Tronics Unlimited, Inc. and its subsidiary Sonotron. All significant intercompany balances and transactions have been eliminated in consolidation.

USE OF ESTIMATES

These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and, accordingly, require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. Significant estimates made by management include expected economic life and value of our medical devices, reserves, deferred tax assets, valuation allowance, impairment of long lived assets, fair value of equity instruments issued to consultants for services and fair value of equity instruments issued to others, option and warrant expenses related to compensation to employees and directors, consultants and investment banks, allowance for doubtful accounts, and warranty reserves. Actual results could differ from those estimates.

REVENUE RECOGNITION

CHEMICAL PRODUCTS:

Revenues are recognized when products are shipped to end users. Shipments to distributors are recognized as revenue when no right of return exists.

ELECTRONICS:

We recognize revenue from the sale of our electronic products when they are shipped to the purchaser. We offer a limited 90 day warranty on our electronics products and a limited 5 year warranty on our electronic controllers for spas and hot tubs. We have no other post shipment obligations. Based on prior experience, no amounts have been accrued for potential warranty costs and actual costs were less than $2,000, for each of the fiscal years ended March 31, 2015 and 2014. For contract manufacturing, revenues are recognized after shipment of the completed products.

ENGINEERING SERVICES:

We provide certain engineering services, including research, development, quality control and quality assurance services along with regulatory compliance services. We recognize revenue from engineering services as the services are provided.

NET INCOME PER SHARE

Basic net income per share is calculated based on the weighted average number of common shares outstanding during the periods. Diluted net income per share is computed similar to basic income per share, except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential shares had been issued and if the additional shares were dilutive.

Per share basic and diluted net income amounted to $0.01 for both the three and six months ended September 30, 2015 and $0.00 for both the three and six months ended ~~June~~September 30, ~~2015 and 2014, respectively.~~2014. There were 3,600,000 and 600,000 common stock equivalents at ~~June~~September 30, 2015 and 2014, respectively.

RECLASSIFICATION

Certain items in the prior financial statements have been reclassified to conform to the current period presentation.

RECENT ACCOUNTING PRONOUNCEMENTS

Management does not believe that any recently issued, but not yet effective accounting pronouncement, if adopted, would have a material effect on the accompanying condensed consolidated financial statements.

The Company values its inventories onat the first in, first out ("FIFO") method at the lower of cost or market.

NOTE 4 – CONCENTRATIONS

During the three month period ended ~~June~~September 30, 2015, one customer accounted for ~~46%~~42% of our ~~revenue and approximately 48% of our accounts receivable as of June 30, 2015.~~

revenue.

During the three month period ended ~~June~~September 30, 2014, one customer accounted for 18% of our revenue.

During the six month period ended September 30, 2015, one customer accounted for 42% of our revenue. As of September 30, 2015, one customer represented approximately 50% of our accounts receivable.

During the six month period ended September 30, 2014, one customer accounted for 18% of our revenue. As of ~~June~~September 30, 2014, three customers represented approximately ~~52%~~42% of our accounts receivable.

The Company’s customer base is comprised of ~~domestic~~foreign and ~~foreign~~domestic entities with diverse demographics. Revenues from foreign customers represented ~~$101,313~~$98,411 of net revenue or ~~9.6%~~7.9% for the three months ended ~~June~~September 30, 2015 and ~~$40,095~~$90,540 of net revenue or ~~6.4%~~12.1% for the three months ended ~~June~~September 30, 2014.

Revenues from foreign customers represented $199,638 of net revenue or 8.6% for the six months ended September 30, 2015 and $130,635 of net revenue or 9.5% for the six months ended September 30, 2014.

As of ~~June~~September 30, 2015 and 2014, accounts receivable included ~~$50,637~~$35,241 and ~~$4,300,~~$23,128, respectively, from foreign customers.

NOTE5 - SEGMENT INFORMATION

Information about segments is as follows:

		Chemical		Electronics			Engineering			Total			Chemical			Electronics			Engineering			Total
Three months ended June 30, 2015

Three months ended September 30, 2015												Three months ended September 30, 2015
Revenue from external customers												Revenue from external customers	$	385,072		$	202,374		$	665,435		$	1,252,881
Segment operating (loss)												Segment operating (loss)	$	(141,767	)	$	(62,222	)	$	(143,926	)	$	(347,915	)

Six months ended September 30, 2015												Six months ended September 30, 2015
Revenue from external customers	Revenue from external customers	$	365,944	$	175,229		$	514,755		$	1,055,928	Revenue from external customers	$	751,016		$	377,603		$	1,180,190		$	2,308,809
Segment operating income (loss)	Segment operating income (loss)	$	200,900	$	15,668		$	217,980		$	434,548	Segment operating income (loss)	$	59,133		$	(46,554	)	$	74,050		$	86,629

Year ended June 30, 2014
Three months ended September 30, 2014												Three months ended September 30, 2014
Revenue from external customers												Revenue from external customers	$	340,470		$	318,203		$	89,920		$	748,593
Segment operating income												Segment operating income	$	67,924		$	29,756		$	31,106		$	128,786

Six months ended September 30, 2015												Six months ended September 30, 2015
Revenue from external customers	Revenue from external customers	$	297,159	$	242,210		$	84,305		$	623,674	Revenue from external customers	$	637,629		$	560,413		$	174,225		$	1,372,267
Segment operating income (loss)	Segment operating income (loss)	$	87,479	$	(8,836	)	$	(42,909	)	$	35,734	Segment operating income (loss)	$	155,403		$	20,920		$	(11,804	)	$	164,519

Total assets at June 30, 2015		$	578,168	$	276,851		$	813,277		$	1,668,296
Total assets at September 30, 2015												Total assets at September 30, 2015	$	1,026,393		$	516,007		$	1,612,786		$	3,155,085

Total assets at March 31, 2015	Total assets at March 31, 2015	$	509,738	$	389,011		$	442,868		$	1,341,417	Total assets at March 31, 2015	$	509,732		$	389,005		$	442,680		$	1,341,417

N~~OTE~~NOTE 6 - OPTIONS OUTSTANDING

During 2013, ADM granted an aggregate of 5,600,000 stock options to employees and consultants expiring at various dates through ~~fiscal 2015.~~March 2016. During 2014, 5,000,000 of the outstanding stock options were exercised. ~~The~~

On September 2, 2015, ADM granted an additional 3,000,000 stock options ~~had various~~to employees at an exercise ~~prices~~price of $0.20 per option and ~~were fully vested at the date~~with a term of ~~grant.~~three years. The options were valued at ~~$55,997~~$598,699 using the Black Scholes option pricing model with the following assumptions: risk free interest rate of ~~4.9%~~2.03%, volatility of ~~414%~~353%, estimated useful life of ~~1.5~~3 years, and dividend rate of 0%.

The following table summarizes information on all common share purchase options issued by us as of ~~June~~September 30, 2015 and 2014.

	2015				2014					2015				2014

	# of Shares		Weighted Average Exercise Price		# of Shares			Weighted Average Exercise Price		# of Shares		Weighted Average Exercise Price		# of Shares			Weighted Average Exercise Price

Outstanding, beginning of year		600,000	$	0.01		5,600,000		$	0.01		600,000	$	0.02		5,600,000		$	0.01

Issued		-	$	-		-		$	-		3,000,000	$	0.20		-		$	-

Exercised		-	$	-		(5,000,000	)	$	0.01		-	$	-		(5,000,000	)	$	0.01

Expired		-	$	-		-		$	-		-	$	-		-		$	-

Outstanding, end of year		600,000	$	0.01		600,000		$	0.01		3,600,000	$	0.17		600,000		$	0.02

Exercisable, end of year		600,000	$	0.01		600,000		$	0.01		3,600,000	$	0.17		600,000		$	0.02

NOTE 7 - COMMITMENTS AND CONTINGENCIES

We lease our office and manufacturing facility under a non-cancelable operating lease, which expires on June 30, 2019. The Company’s future minimum lease commitment at ~~June~~September 30, 2015 is as follows:

For the twelve month period ending June 30,	Amount
For the twelve month period ended September 30,			Amount
2016	$	104,625	$	104,625
2017		104,625		104,625
2018		104,625		78,469
	$	313,875	$	287,719

Rent and real estate tax expense for all facilities for the ~~three~~six months ended ~~June~~September 30, 2015 and 2014 was approximately ~~$31,000 respectively,~~$63,000 for each period.

On February 12, 2010, ADM agreed to provide certain services to Ivivi Health Sciences, LLC (IHS) pursuant to a Master Services Agreement, as described below:

NOTE8 - INCOME TAXES

At ~~June~~September 30, 2015, the Company had federal and state net operating loss carry-forwards ("NOL")'s of approximately ~~$3,800,000,~~$3,692,000, which are due to expire through fiscal ~~2034~~2034.: These NOLs may be used to offset future taxable income through their respective expiration dates and thereby reduce or eliminate our federal and state income taxes otherwise payable. A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. Ultimate utilization of such NOL's and credits is dependent upon .the Company's ability to generate taxable income in future periods and may be significantly curtailed if a significant change in ownership occurs.

Due to the uncertainty related to future taxable income, the Company provides a ~~100%~~partial valuation allowance for the deferred tax benefit resulting from the NOL's and depreciation and amortization. During the six months ended September 30, 2015, the Company utilized approximately $700,000 in net operating losses and expects to utilize $2,800,000 before expiration. For the three and six months ended September 30, 2015, the $857,000 benefit for deferred income taxes results from a reduction in the valuation allowance.

NOTE 1010 – SUBSEQUENT EVENTS

~~On August 7, 2015~~We evaluated all subsequent events from the ~~Company sold 2,068,965 shares~~date of ~~its $.0005 par value common stock to Advanced Plasma Therapies, Inc. (“APT”) for $300,000. The shares purchased by APT~~the condensed consolidated balance sheet through the issuance date of this report and determined that there are ~~restricted securities and have not been registered for public sale. APT is a privately-held company involved~~no events or transactions occurring during the subsequent event reporting period which require recognition or disclosure in the development and commercialization of innovative therapeutic medical plasma technologies. The Company has been providing APT with engineering services for APT's plasma-based medical technologies currently in clinical development and is expected to manufacture APT products for clinical use and for commercial deployment following receipt of applicable regulatory approvals. condensed consolidated financial statements.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion of our operations and financial condition should be read in conjunction with the condensed consolidated financial statements and notes thereto included elsewhere in this Quarterly Report on Form 10-Q.

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the "safe harbor" provisions under section 21E of the Securities and Exchange Act of 1934 and the Private Securities Litigation Act of 1995. We use forward-looking statements in our description of our plans and objectives for future operations and assumptions underlying these plans and objectives. Forward-looking terminology includes the words "may", "expects", "believes", "anticipates", "intends", "forecasts", "projects", or similar terms, variations of such terms or the negative of such terms. These forward-looking statements are based on management's current expectations and are subject to factors and uncertainties which could cause actual results to differ materially from those described in such forward-looking statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained in this Form 10-Q to reflect any change in our expectations or any changes in events, conditions or circumstances on which any forward-looking statement is based. Factors which could cause such results to differ materially from those described in the forward-looking statements include those set forth under "Item. 1 Description of Business – Risk Factors" and elsewhere in or incorporated by reference into our Annual Report on Form 10-K for the year ended March 31, 2015.

We recognize revenue from engineering services on a project or monthly basis and contract manufacturing revenues are recognized after shipment of completed products. For the sale of our electronic products, revenues are recognized when they are shipped to the ~~purchaser..~~purchaser. Shipping and handling charges and costs are de minimis. We offer a limited 90 day warranty on our electronics products and a limited 5 year warranty on our electronic controllers for spas and hot tubs. Historically, the amount of warranty revenue included in the sales of our electronic products have been de minimis. We have no other post shipment obligations and sales returns have been de minimis.

Revenues from sales of chemical products are recognized when products are shipped to end users. Shipments to distributors are recognized as sales where no right of return exists.

Our discussion and analysis of our financial condition and results of operations is based upon our condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these condensed consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to reserves, deferred tax assets and valuation allowance, impairment of long-lived assets, fair value of equity instruments issued to consultants for services and fair value of equity instruments issued to others. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions; however, we believe that our estimates, including those for the above described items, are reasonable.

ADM is a corporation that was organized under the laws of the State of Delaware on November 24, 1969. During the ~~three~~six months ended ~~June~~September 30, 2015 and 2014, our operations are conducted through ADM Tronics Unlimited, Inc. ("ADM") and its subsidiary, Sonotron Medical Systems, Inc. ("SMI"). In addition, the Company owns a minority interest in Montvale Technologies, Inc. (formerly known as Ivivi Technologies, Inc.) ("ITI"), which until October 18, 2006 was operated as a subsidiary of the Company. ITI was deconsolidated as of October 18, 2006 upon the consummation of ITI's initial public offering.

We are a technology-based engineering and manufacturing company with diversified lines of products in the following four areas: (1) electronic products for numerous industries, including therapeutic non-invasive electronic medical devices and electronic controllers for spas and hot tubs, (2) environmentally safe chemical products for industrial use, (3) cosmetic and topical dermatological products and (4) antistatic paint and coatings products.

RESULTS OF OPERATIONS FOR THE THREEAND SIXMONTHS ENDED ~~JUNE~~SEPTEMBER 30, 2015 AS COMPARED TO ~~JUNE~~SEPTEMBER 30,~~, 201~~4 2014

Revenues ~~were $1,055,928~~ for the three months ended ~~June~~September 30, 2015 ~~as compared~~increased by $504,288, or 67% due to ~~$623,674 for the three months ended June 30, 2014, an increase of $432,254, or 69%. The increase resulted from~~ an increase in engineering revenue of ~~$430,450~~$575,515 coupled with an increase in sales in our chemical division of ~~$68,785~~$44,602 offset by a decrease in our electronic segment in the amount of ~~$66,981.~~$115,829. The increase in engineering services is primarily the result of several projects for one customer.

Revenues for the six months ended September 30, 2015 increased by $936,542 or 68% due to an increase in engineering revenue of $1,005,965 coupled with an increase in sales in our chemical division of $113,387 offset by a decrease in our electronic segment in the amount of $182,810. The increase in engineering services is primarily the result of several projects for one customer.

Gross profit ~~was $755,055, or 71.5%,~~ for the three months ended ~~June~~September 30, 2015 ~~and $285,458, or 45.8%~~increased by $272,477. Gross profit for the ~~three~~six months ended ~~June~~September 30, ~~2014.~~2014 increased by $742,074. The increase in gross profit in the electronics and chemical segments resulted from changes in the mix of products sold. The increase in gross profit in the engineering segment resulted from better utilization of labor due to the increased revenue from new projects from one customer.

We are highly dependent upon certain ~~customers to generate our revenues.~~customers. During the three ~~month period~~and six months ended ~~June~~September 30, 2015 one customer accounted for ~~46%~~42% of our revenue. During the three ~~month period~~and six months ended ~~June~~September 30, 2014, ~~another~~one customer accounted for 18% of our revenue. The complete loss of or significant reduction in business from, or a material adverse change in the financial condition of any of our customers could cause a material and adverse change in our revenues and operating results.

Income from operations for the three months ended ~~June~~September 30, 2015 ~~was $434,548 compared~~decreased by $476,701 due to ~~$35,734 for the three months ended June 30, 2014.~~stock based compensation of $598,699. Selling, general, and administrative expenses increased by ~~$59,184~~$153,685 or ~~25%~~48%, from ~~$236,037~~$321,501 to ~~$295,221~~$475,186 mainly due to an increase of ~~$40,383 in royalties and commissions and~~$28,884 wages, a ~~$17,614~~$23,560 increase in commission and royalty fees, $39,860 in consulting ~~fees.~~fees, $54,383 in engineering fees and $13,437 in insurance.

Income from operations for the six months ended September 30, 2015 decreased by $77,890. Selling, general, and administrative expenses increased by $196,714 or 34% from $573,697 to $770,411 mainly due to an increase of $40,021 in wages, $63,944 in commission and royalty fees and an increase in contract services of $37,974.

During the six months ended September 30, 2015, we had $598,699 of stock based compensation related to 3,000,000 options granted to employees. There was no stock based compensation for the six months ended September 30, 2014.

Interest income decreased ~~$726~~$1,077 to ~~$321~~$248 in the three months ended ~~June~~September 30, 2015, from ~~$1,047~~$1,325 in the three months ended ~~June~~September 30, 2014 and interest income decreased $1,803 to $569 in the six months ended September 30, 2015 from $2,372 in the six months ended September 30, 2014 due to decreased funds invested in a money market account.

For the three and six months ended September 30, 2015, the $857,000 credit for deferred income taxes results from a reduction in the valuation allowance.

The foregoing resulted in net income for the three months ended ~~June~~September 30, 2015 of ~~$434,228,~~$508,503, or $0.01 per share, compared to net income for the three months ended ~~June~~September 30, 2014 of ~~$35,828~~$129,371 or $0.00 per share.

The net income for the six months ended September 30, 2015 and 2014 was $942,727 or $0.01 per share and $165,198 or $0.00 per share, respectively.

At ~~June~~September 30, 2015, we had cash and cash equivalents of ~~$370,526~~$942,143 as compared to $216,395 at March 31, 2015. The ~~$154,131~~$725,748 increase was primarily the result of cash provided in operations during the ~~three~~six month period in the amount of ~~$161,392 offset by~~$439,097 and cash ~~used~~provided in financing activities in the amount of ~~$7,000 and~~$287,000 offset by cash used in investing activities of ~~$261.~~$349. Our cash will continue to be used for increased marketing costs, and the related administrative expenses, in order to attempt to increase our revenue. We expect to have enough cash to fund operations for the next twelve months. Our note payable of ~~$114,966~~$108,966 at ~~June~~September 30, 2015, is secured and collateralized by restricted cash of ~~$232,786.~~$232,874. This note bears an interest rate of 2% above the rate of the savings account. The interest rate at ~~June~~September 30, 2015 was 2.15% and is payable upon demand.

We expect that growth in profitable revenues and continued focus on new customers will enable us to continue to generate cash flows from operating activities during fiscal 2016.

If we do not generate sufficient cash from operations, face unanticipated cash needs or do not otherwise have sufficient cash, we may need to consider the sale of certain intellectual property which does not support the Company’s operations. In addition, we have the ability to reduce certain expenses depending on the level of business operation.

Based on current expectations, we believe that our existing cash of ~~$370,526~~$942,143 as of ~~June~~September 30, 2015 and other potential sources of cash will be sufficient to meet our cash requirements. Our ability to meet these requirements will depend on our ability to generate cash in the future, which is subject to general economic, financial, competitive, legislative, regulatory and other factors that are beyond our control.

Net cash provided ~~(used)~~ by operating activities was ~~$161,392~~$439,097 for the ~~three~~six months ended ~~June~~September 30, 2015, as compared to net cash ~~used in~~provided by operating activities of ~~$(9,262)~~$85,040 for the ~~three~~six months ended ~~June~~September 30, 2014. The cash provided during the ~~three~~six months ended ~~June~~September 30, 2015 was primarily due to net income of ~~$434,228~~$942,727, stock based compensation of $598,699, deferred income tax of $857,000 and decreases in operating liabilities of ~~$100,349,~~$14,759, and net operating assets of ~~$173,287.~~$232,170.

Cash was used in investing activities in the amount of ~~$261~~$349 from deposits in the restricted cash in the amount of ~~$261.~~$349.

For the ~~three~~six months ended ~~June~~September 30, 2015 and 2014, net cash ~~used~~provided (used) in financing activities were $287,000 and $(7,000), respectively. For the six months ended September 30, 2015 and 2014, $13,000 and $7,000 ~~and $4,000,~~ respectively, ~~which were~~was used for repayments on a note from a commercial bank to facilitate our acquisition of Action Industries Unlimited, Inc. (AIU).

Additionally, during the six months ended September 30, 2015, $300,000 was provided for through the sale of common stock to a major customer.

We have no off-balance sheet arrangements that have had or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

Financial instruments that potentially subject us to significant concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable and our investment in ITI. We have no control over the market value of our investment in ITI.

Our sales are materially dependent on a small group of customers, as noted in Note 4 of our condensed consolidated financial statements. We monitor our credit risk associated with our receivables on a routine basis. We also maintain credit controls for evaluating and granting customer credit.

The Company's management, including the Company's principal executive officer and principal financial officer, have evaluated the effectiveness of the Company's "disclosure controls and procedures," as such term is defined in Ru1e 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended, (the "Exchange Act"). Based upon their evaluation, the principal executive officer and principal financial officer concluded that, as of the end of the period covered by this report, the Company's disclosure controls and procedures were not effective for the purpose of ensuring that the information required to be disclosed in the reports that the Company files or submits under the Exchange Act with the Securities and Exchange Commission (the "SEC") (1) is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and (2) is accumulated and communicated to the Company's management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. During the quarterly period ended ~~June~~September 30, 2015, there were no changes in the Company's internal control over financial reporting which materially affected, or are reasonably likely to materially affect, the Company's internal controls over financial reporting.

The determination that our disclosure controls and procedures were not effective as of ~~June~~September 30, 2015 are a result of:

a.Deficiencies in Internal Control Structure Environment.~~The Company experienced net losses for the past several years.~~ During the current year, the Company’s focus was on expanding their customer base to initiate revenue production.

b.Inadequate staffing and supervision within the accounting operations of our company.The relatively small number of employees who are responsible for accounting functions prevents the Company from segregating duties within its internal control system. The inadequate segregation of duties is a weakness because it could lead to the untimely identification and resolution of accounting and disclosure matters or could lead to a failure to perform timely and effective reviews. The Company’s plan is to expand its accounting operations as the business of the Company expands.

The Company believes that the financial statements fairly present, in all material respects, the Company’s condensed consolidated balance sheets as of ~~June~~September 30, 2015 and March 31, 2015 and the related condensed consolidated statements of operations, ~~stockholders’ equity (deficiency),~~ and cash flows for the three and six months ended ~~June~~September 30, 2015 and 2014, in conformity with generally accepted accounting principles, notwithstanding the material weaknesses we identified.

There were no changes in our internal control over financial reporting that occurred during our last fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

There have been no material changes to the risk factors contained in our Annual Report on Form 10-K for the year ended March 31, 2015.

31.1 Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1 Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

** XBRL information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Large accelerated filer [ ]	Accelerated filer [ ]

Non-accelerated filer [ ] (Do not check if a smaller reporting company)	Smaller reporting company [X]

		Page
		Number
Part I - Financial Information

Item 1.	Condensed Consolidated Financial Statements:

	Condensed Consolidated Balance Sheets – ~~June~~September 30, 2015 (unaudited) and March 31, 2015		3

	Condensed Consolidated Statements of Operations for the three and six months ended ~~June~~September 30, 2015 and 2014 (unaudited)		4

	Condensed Consolidated Statements of Cash Flow for the ~~three~~six months ended ~~June~~September 30, 2015 and 2014 (unaudited)		5

	Notes to the Condensed Consolidated Financial Statements (unaudited)		6

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		10

Item 3.	Quantitative and Qualitative Disclosures about Market Risk		1416

Item 4.	Controls and Procedures		1416

Part II - Other Information

Item 1.	Legal Proceedings		1517

Item 1A.	Risk Factors		1517

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		1517

Item 3.	Defaults Upon Senior Securities		1517

Item 4.	Mine Safety Disclosures		1517

Item 5.	Other Information		1517

Item 6.	Exhibits		1518

		Current		Long Term		Total		Current		Long Term		Total
Raw materials	Raw materials	$	139,584	$	84,285	$	223,869	$	170,822	$	74,113	$	244,935
Finished Goods	Finished Goods		27,208		619		27,827		22,927		526		23,453
		$	166,792	$	84,904	$	251,696	$	193,749	$	74,639	$	268,388

	Current		Long Term		Total
Raw materials	$	95,702	$	87,638	$	183,340
Finished Goods		42,002		619		42,621
	$	137,704	$	88,257	$	225,961

For the Three Months Ended June 30, 2015
	Chemical			Electronics			Engineering			Total
Revenue	$	365,944		$	175,229		$	514,755		$	1,055,928
Cost of Sales		53,949			106,350			140,574			300,873
Gross Profit		311,995			68,879			374,181			755,055
Gross Profit Percentage		85	%		39	%		73	%		72	%

Operating Expenses		111,073			53,203			156,231			320,507
Operating Income		200,922			15,676			217,950			434,548
Other income (expenses)		(154	)		(54	)		(112	)		(320	)
Net Income	$	200,768		$	15,622		$	217,838		$	434,228

For the Three Months Ended June 30, 2014
	Chemical			Electronics			Engineering			Total
Revenue	$	297,159		$	242,210		$	84,305		$	623,674
Cost of Sales		90,694			154,064			93,458			338,216
Gross Profit		206,465			88,146			(9,153	)		285,458
Gross Profit Percentage		69	%		36	%		-11	%		46	%

Operating Expenses		118,986			96,982			33,756			249,724
Operating Income (Loss)		87,479			(8,836	)		(42,909	)		35,734
Other income (expenses)		44			37			13			94
Net Income (Loss)	$	87,523		$	(8,799	)	$	(42,896	)	$	35,828

Variance
	Chemical			Electronics			Engineering			Total
Revenue	$	68,785		$	(66,981	)	$	430,450		$	432,254
Cost of Sales		(36,745	)		(47,714	)		47,116			(37,343	)
Gross Profit		105,530			(19,267	)		383,334			469,597
Gross Profit Percentage		16	%		3	%		84	%		26	%

Operating Expenses		(7,913	)		(43,779	)		122,475			70,783
Operating Income (Loss)		113,443			24,512			260,859			398,814
Other income (expenses)		(198	)		(91	)		(125	)		(414	)
Net Income	$	113,245		$	24,421		$	260,734		$	398,400

	2015			2014

Net revenues	$	1,055,928		$	623,674

Cost of sales		300,873			338,216

Gross Profit		755,055			285,458

Operating expenses:
Research and development		24,689			12,045
Selling, general, and administrative		295,221			236,037
Depreciation and amortization		597			1,642

Total operating expenses		320,507			249,724

Income from operations		434,548			35,734

Other income (expense):
Interest income		321			1,047
Interest expense		(641	)		(953	)
Total other income (expense)		(320	)		94


Net income	$	434,228		$	35,828

Basic and diluted net income per common share:	$	0.01		$	0.00

Weighted average shares of common stock outstanding - basic		64,939,537			64,939,537

Weighted average shares of common stock outstanding - diluted		65,539,537			65,539,537

	Three months ended						Six months ended
	September 30,						September 30,
	2015			2014			2015			2014

Net revenues	$	1,252,881		$	748,593		$	2,308,809		$	1,372,267

Cost of sales		495,680			263,869			796,553			602,085

Gross Profit		757,201			484,724			1,512,256			770,182

Operating expenses:
Research and development		30,522			18,241			55,211			30,286
Selling, general and administrative		475,186			337,142			770,411			573,697
Stock based compensation		598,699			-			598,699			-
Depreciation and amortization		709			555			1,306			1,680

Total operating expenses		1,105,116			355,938			1,425,627			605,663

Income (loss) from operations		(347,915	)		128,786			86,629			164,519

Other income (expense):
Interest income		248			1,325			569			2,372
Interest expense		(830	)		(740	)		(1,471	)		(1,693	)
Total other income (expense)		(582	)		585			(902	)		679

Income (loss) before benefit for income taxes		(348,497	)		129,371			85,727			165,198
Benefit for income taxes - deferred		857,000			-			857,000			-

Net income	$	508,503		$	129,371		$	942,727		$	165,198

Basic and diluted per common share:	$	0.01		$	0.00		$	0.01		$	0.00

Weighted average shares of common stock outstanding - basic		66,176,418			64,939,537			65,561,357			64,939,537

Weighted average shares of common stock outstanding - diluted		66,994,600			65,539,537			66,379,539			65,539,537

For the Three Months Ended September 30, 2014
	Chemical			Electronics			Engineering			Total
Revenue	$	340,470		$	318,203		$	89,920		$	748,593
Cost of Sales		110,108			138,086			15,675			263,869
Gross Profit		230,362			180,117			74,245			484,724
Gross Profit Percentage		68	%		57	%		83	%		65	%

Operating Expenses		162,438			150,361			43,139			355,938
Operating Income (Loss)		67,924			29,756			31,106			128,786
Other income (expenses)		272			240			73			585
Income (loss) before benefit from income taxes	$	68,196		$	29,996		$	31,179		$	129,371

For the Six Months Ended September 30, 2015
	Chemical			Electronics			Engineering			Total
Revenue	$	751,016		$	377,603		$	1,180,190		$	2,308,809
Cost of Sales		228,154			191,000			377,399			796,553
Gross Profit		522,862			186,603			802,791			1,512,256
Gross Profit Percentage		70	%		49	%		68	%		65.5	%

Operating Expenses		463,729			233,157			728,741			1,425,627
Operating Income (Loss)		59,133			(46,554	)		74,050			86,629
Other income (expenses)		(294	)		(148	)		(460	)		(902	)
Income (loss) before benefit from income taxes	$	58,839		$	(46,702	)	$	73,590		$	85,727

101.INS**	XBRL Instance
101.SCH**	XBRL Taxonomy Extension Schema
101.CAL**	XBRL Taxonomy Extension Calculation
101.DEF**	XBRL Taxonomy Extension Definition
101.LAB**	XBRL Taxonomy Extension Labels
101.PRE**	XBRL Taxonomy Extension Presentation

	ADM TRONICS UNLIMITED, INC.
	(Registrant)


	By:	/s/ Andre' DiMino
		Andre' DiMino, Chief Executive
		Officer and Chief Financial Officer

Variance
	Chemical			Electronics			Engineering			Total
Revenue	$	44,602		$	(115,829	)	$	575,515		$	504,288
Cost of Sales		64,097			(53,436	)		221,150			231,811
Gross Profit		(19,495	)		(62,393	)		354,365			272,477
Gross Profit Percentage		-13	%		2	%		-18	%		-4	%

Operating Expenses		190,196			29,585			529,397			749,178
Operating Income (Loss)		(209,691	)		(91,978	)		(175,032	)		(476,701	)
Other income (expenses)		(412	)		(334	)		(421	)		(1,167	)
Income (loss) before benefit from income taxes	$	(210,103	)	$	(92,312	)	$	(175,453	)	$	(477,868	)

Variance
	Chemical			Electronics			Engineering			Total
Revenue	$	113,387		$	(182,810	)	$	1,005,965		$	936,542
Cost of Sales		27,352			(101,150	)		268,266			194,468
Gross Profit		86,035			(81,660	)		737,699			742,074
Gross Profit Percentage		1	%		2	%		31	%		9	%

Operating Expenses		182,305			(14,186	)		651,845			819,964
Operating Income (Loss)		(96,270	)		(67,474	)		85,854			(77,890	)
Other income (expenses)		(610	)		(425	)		(546	)		(1,581	)
Income (loss) before benefit from income taxes	$	( 96,880	)	$	( 67,899	)	$	85,308		$	( 79,471	)